Search for a trial | Research with human participants

1 results

An open-label, multicentre, integrated Phase 1 & 2 study to evaluate the safety, tolerability, radiation dosimetry and anti-tumour activity of Lutetium (177Lu) rhPSMA 10.1 injection in men with metastatic castrate resistant prostate cancer

Approved WMORecruiting

This study has been transitioned to CTIS with ID 2024-511537-35-00 check the CTIS register for the current data. Phase 1• To establish the RP2D regimen by evaluation of the safety and tolerability of intravenous (IV) administration of Lutetium (…